Dynavax Embraces New Opportunities at Investor Conferences

Author: Evelyn Baker Updated: 02-25-2025 04:27 PM

Dynavax Technologies Corporation: Engaging with Investors

Dynavax Technologies Corporation (Nasdaq: DVAX) is a prominent player in the biopharmaceutical industry, renowned for its commitment to developing and commercializing innovative vaccines. With a focus on protecting individuals from infectious diseases, Dynavax is poised to make significant strides in the healthcare sector. Recently, the company announced its plans to partake in several upcoming investor conferences, offering an opportunity for stakeholders to engage with its initiatives and achievements.

Upcoming Investor Conferences

The company is set to participate in key investor conferences, which are crucial for enhancing visibility and building relationships with potential investors. The schedule includes:

TD Cowen 45th Annual Healthcare Conference

This notable event will take place on Tuesday, March 4, providing a platform for dialogue and updates regarding their advancements in vaccine technologies.

Barclays 27th Annual Global Healthcare Conference

Shortly after, on Tuesday, March 11, Dynavax will also present at the Barclays conference. These presentations will feature essential insights into the company’s latest developments and future plans.

Webcast Access and Information

Both presentations from these conferences will be accessible via webcasts. To view these and learn more about the company’s offerings, you can visit the "Events & Presentations" page in the "Investors" section of the Dynavax website.

About Dynavax Technologies

Founded with the mission to revolutionize vaccine development, Dynavax holds a strong portfolio enriched with innovative products. The commercial-stage biopharmaceutical company has made a significant impact through its HEPLISAV-B vaccine, which is approved for use not only in the United States but also in the European Union and the United Kingdom. This vaccine addresses the prevention of hepatitis B infections for adults, showcasing the company’s dedication to public health.

Additionally, the company has developed the CpG 1018 adjuvant, integral to both HEPLISAV-B and several COVID-19 vaccines. This advancement highlights Dynavax’s ongoing commitment to tackling pressing health challenges.

Investor Relations and Contact

For media inquiries and investment information, Dynavax has dedicated personnel available:

Contact Information

Paul Cox,

Phone: 510-665-0499

Nicole Arndt,

Phone: 510-665-7264

Frequently Asked Questions

What is Dynavax Technologies Corporation known for?

Dynavax is a biopharmaceutical company focused on innovative vaccines aimed at infectious diseases.

What conferences is Dynavax participating in?

Dynavax will participate in the TD Cowen 45th Annual Healthcare Conference and the Barclays 27th Annual Global Healthcare Conference.

How can I access Dynavax's conference presentations?

Presentations can be accessed through the "Events & Presentations" page on Dynavax's website.

What products does Dynavax offer?

Dynavax’s products include HEPLISAV-B, a hepatitis B vaccine, and the CpG 1018 adjuvant used in various vaccines.

Who can I contact for investor inquiries at Dynavax?

For investor inquiries, you can contact Paul Cox or Nicole Arndt at the provided phone numbers.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.